0.1 to 0.5 Percent of SARS-CoV-2 Infections Become Persistent
In some individuals, there were many viral amino acid substitutions, indicating strong positive selection
2023 to 2024 Seasonal Influenza Vaccine Effective for Reducing Risk
VE against influenza-linked outpatient visits ranged from 33 to 49 percent, and against hospitalization from 41 to 44 percent among adults
Health Officials Recommend Spring COVID-19 Booster for Older Adults
Second booster appropriate as long as at least four months have passed since last COVID-19 shot
Tetanus Vaccine May Be in Short Supply After Company Stops Production
Sanofi plans to ramp up production of its version, but doctors should switch to Tdap shot in the meantime
Guidelines Developed for Diagnosis, Management of Cryptococcosis
Accurate delineation of cryptococcosis clinical syndrome is important as it guides choice, duration of treatment
AGA Recommends Fecal Microbiota Transplant for Recurrent C. Difficile
Transplant is recommended on completion of standard-of-care antibiotics for immunocompetent adults with recurrent infection
Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib
Baricitinib plus remdesivir linked to reduced risk of death, progression to invasive mechanical ventilation
Level of Burnout Higher for Women in Health Care Occupations
Gender-specific factors that have direct link to well-being include job satisfaction, psychological health, and work-life integration
Fungal Keratitis Prevalence Twice as High in Rural Versus Nonrural Areas
Many patients with fungal keratitis prescribed antibiotics, steroids
Maternal Booster COVID-19 Vaccination Protects Infants Through 6 Months
For each 10-fold increase in Spike IgG titer at delivery, risk for infection reduced 47 percent for infants, regardless of boost
